| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 97 |
| 1 | METHOTREXATE SODIUM | 75 |
| 2 | PREDNISONE | 75 |
| 3 | METHOTREXATE | 64 |
| 4 | PREDNISOLONE | 45 |
| 5 | PREDNISOLONE ORAL | 45 |
| 6 | PREDNISOLONE ORAL SOLUTION | 45 |
| 7 | TACROLIMUS | 40 |
| 8 | MYCOPHENOLATE MOFETIL | 39 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUPREDNATE OPHTHALMIC | 3 | 0.0034 |
| 1 | ETRAVIRINE | 9 | 0.0020 |
| 2 | ADALIMUMAB-AFZB | 5 | 0.0019 |
| 3 | RALTEGRAVIR | 9 | 0.0017 |
| 4 | MECHLORETHAMINE HYDROCHLORIDE | 3 | 0.0013 |
| 5 | ACITRETIN | 4 | 0.0008 |
| 6 | DIFLUPREDNATE | 3 | 0.0008 |
| 7 | BETAMETHASONE DIPROPIONATE | 5 | 0.0007 |
| 8 | THIOTEPA | 7 | 0.0007 |
| 9 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 7 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 155 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 100 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 65 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 62 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 38 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 36 |
| 6 | Kinase Inhibitor [EPC] | 35 |
| 7 | Vitamin C [EPC] | 33 |
| 8 | Vitamin B12 [EPC] | 31 |
| 9 | Provitamin D2 Compound [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 3 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 5 | Benzothiazole [EPC] | 2 | 0.0009 |
| 6 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |
| 7 | Interleukin-17A Antagonist [EPC] | 24 | 0.0006 |
| 8 | Tetracycline-class Antibacterial [EPC] | 5 | 0.0006 |
| 9 | Skin Test Antigen [EPC] | 1 | 0.0005 |